Изменения иммунной системы в патогенезе нейрофиброматоза 1-го типа the oncosuppressor neurofibromin. The disease has a specific progressive course with
multiple neurofibromas
Kazantseva, A.V.,
Davydova, Yu. D.,
Enikeeva, R.F.,
Mustafin, R.N.,
Lobaskova, M.M.,
Malykh, S.B.,
Khusnutdinova, E.K. (2022) and individual differences in depression level in the studied sample. Nevertheless,
multiple regression analysis
Kazantseva, A.,
Enikeeva, R.,
Takhirova, Z.,
Davydova, Y.,
Mustafin, R.,
Malykh, S.,
Karunas, A.,
Kanapin, A.,
Khusnutdinova, E. (2023) To date,
multiple efforts have been made to use genome-wide association studies (GWAS) to untangle
Markelov, V.A.,
Korytina, G.F,
Aznabaeva, Y.G.,
Gibadullin, I.A.,
Akhmadishina, L.Z.,
Nasibullin, T.R.,
Kochetova, O.V.,
Avzaletdinov, A.M.,
Zagidullin, N Sh (2024) prognostic model was constructed based on the
multiple regression and ROC analyses. The model included